Depression is often misunderstood. Friends, family, or even healthcare providers may inadvertently imply that depression results from personal failure or a lack of effort. This misconception can compound feelings of guilt and hopelessness.
At Radiant Minds, we want to be clear: depression is a medical condition. It involves complex brain chemistry and neural pathways, and in some cases, treatment-resistant depression (TRD) requires more advanced approaches.
Why SSRIs and Traditional Medications Sometimes Fail
SSRIs target serotonin, but for many patients, this neurotransmitter-focused approach is not enough. Long-term depression can impair glutamate pathways, which are critical for communication between brain cells. Symptoms may persist despite proper adherence to antidepressants, leaving patients frustrated and exhausted.
How Spravato® Works Differently
Spravato® (Esketamine) targets the glutamate system, promoting neuroplasticity and healing. By focusing on brain pathways overlooked by traditional medications, Spravato® can restore emotional balance and cognitive function. Many patients experience improvement within hours or days, providing critical relief when hope feels distant.
A New Perspective on Healing
Understanding depression as a brain health condition helps remove stigma and shame. It emphasizes that needing specialized treatments like Spravato® is not a personal failure—it’s a medical reality.
At Radiant Minds, our patients learn that depression is treatable, and with the right tools and support, life can improve even after years of struggle.
